News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Mergers and Acquisitions (World)
How Abbott (ABT) is Reaping Rewards From Teva (TEVA)'s Bid for Mylan (MYL) 4/23/2015
Novartis AG (NVS) Hunts for Bolt-On Acquisitions Worth $2 Billion to $5 Billion 4/23/2015
Rumors Swirl Pfizer (PFE) Will Bid for AstraZeneca PLC (AZN) Again 4/23/2015
Teva (TEVA) Files For Hart-Scott-Rodino Notification Regarding Proposed Acquisition Of Mylan (MYL) 4/22/2015
BREAKING: Perrigo (PRGO) Rejects $30B Mylan (MYL) Bid, Says Deal "Substantially Undervalues" Irish Firm 4/21/2015
Teva (TEVA) Finally Makes Mylan (MYL) Bid Official, With $40 Billion Offer For Biggest Takeover in 2015 4/21/2015
Actelion Ltd. (ALIOF.PK) CFO Actively Hunting for M&A Opportunities 4/21/2015
Daiichi Sankyo Dumps $3.6 Billion Sun Pharma (SUNPHARMA.NS) Stake 4/20/2015
Teva (TEVA) Will Bid For Mylan (MYL), Say Sources, As Tug-of-War Continues 4/20/2015
Mallinckrodt (MNK) Completes Acquisition Of Ikaria 4/17/2015
Sartorius Stedim Biotech Acquires UK-based CRO, BioOutsource 4/17/2015
Karo Bio AB Acquires Product For Treatment Of Common Cold 4/10/2015
EXCLUSIVE: Shire (SHPGY) Buyout of BioMarin (BMRN) "Seems Obvious," Source Close to the Deal Tells BioSpace (DHX) 4/2/2015
Valeant (VRX) Completes Acquisition Of Salix (SLXP) 4/1/2015
Dr. Reddy's Laboratories Ltd. (RDY) To Acquire Select Portfolio Of The Established Products Business Of UCB In India 4/1/2015
Teva (TEVA) Shells Out $3.2B to Buy Auspex Pharmaceuticals (ASPX) and Boost CNS Business; All Cash, No Debt 3/31/2015
RedHill Biopharma Ltd. (RDHL) Will Snag Small Molecule Rights from Apogee for $5.5M 3/31/2015
Japan's FUJIFILM to Acquire U.S. Cellular Dynamics for $307M 3/31/2015
Horizon Pharma (HZNP) Acquires Hyperion Therapeutics (HPTX) and Its Revenue-Boosting Pipeline for $1.1B 3/31/2015
Amneal Signs Deal To Acquire The Generic Business Of Actavis (ACT) Australia 3/31/2015
BIOSAFE Goes Direct in Brazil, Acquiring Its Local Distributor 3/30/2015
Columbia Laboratories, Inc. (CBRX) Acquires Exclusive Worldwide License To A Novel Segmented Intra-Vaginal Ring Delivery Technology 3/30/2015
Solasia Acquires Exclusive License And Distribution Rights From Camurus For Episil Oral Liquid In Japan And China 3/30/2015
Novartis AG (NVS) CEO, a San Francisco Native, Takes an Axe to Predecessor's Empire 3/27/2015
Life Post-Ranbaxy Laboratories (RANBAXY.BO)? Sun Pharma (SUNPHARMA.NS) Holds On to $300 Million and Hunts for More M&As 3/25/2015
APR Applied Pharma Research S.A. Today Announced That HBM Partners AG (“HBM”) Has Acquired A Minority Stake In APR 3/25/2015
Recent Signs Mylan (MYL) May be Gobbled Up by Teva (TEVA) 3/23/2015
Cipher Pharmaceuticals (DND.TO) Acquires Canadian Rights To Novel Treatment For Psoriasis And Rheumatoid Arthritis 3/23/2015
AstraZeneca PLC (AZN) Trudges Behind in Cancer Race Where Losing May Force a Buyout 3/20/2015
Genmab A/S (GEN.CO) Acquires Antibody Assets From iDD Biotech 3/18/2015
Pharmalink AB Acquires Novel Therapeutic Product Candidate For Treating Inflammation Associated With Osteoarthritis 3/18/2015
Ignyta (RXDX) Shells Out $41.6 Million for Teva (TEVA)'s Oncology Assets 3/18/2015
Actavis (ACT) Completes Allergan (AGN) Acquisition 3/17/2015
Valeant (VRX) Sweetens Salix (SLXP) Deal to $173 Per Share After Teaming Up With Ackman and Endo International (ENDP) Withdraws 3/16/2015
Valeant (VRX) Announces HSR Clearance For Salix (SLXP) Acquisition 3/16/2015
GlaxoSmithKline (GSK) Pockets $853 Million by Halving Stake in Aspen Pharmacare 3/13/2015
Employees at Three Major Biopharmas Remain Uncertain, As Salix (SLXP) Confirms Bid From Endo International (ENDP) 3/13/2015
Porton Fine Chemicals Pays $41.5 Million To Acquire Dongbang Pharma 3/12/2015
LMC Diabetes & Endocrinology And Manna Research Merge Research Programs 3/12/2015
AbbVie (ABBV), Johnson & Johnson (JNJ) Tempted to Take Over $650 Million Galapagos (GLPG.BR) 3/11/2015
Novartis AG (NVS) Will Move Past Scandal While Hunting for More M&A in the $2-5 Billion Range, Says CEO 3/5/2015
Baxter International (BAX) Snaps Up German Biopharma for $225 Million 3/5/2015
Teva (TEVA) Sells Plant, 25 Drugs to G&W Laboratories; 280 Jobs Salvaged 3/4/2015
Sun Pharma (SUNPHARMA.NS) Snaps Up GlaxoSmithKline (GSK)'s Opiates Business 3/3/2015
ICON Completes Acquisition Of MediMedia Pharma Solutions 3/2/2015
JSR Corporation And KBI BioPharma Agree To Acquisition; INCJ And CMIC Of Japan Also Participate 2/26/2015
Phosphagenics Limited (POH.AX) Decides To Sell BioElixia Cosmetics Brand 2/25/2015
Bristol-Myers Squibb (BMY) Snaps Up Private Cancer Drugmaker in $1.25 Billion Buyout 2/24/2015
Ipsen (IPN.PA) Enters Into Option Agreement To Acquire Canbex Therapeutics 2/24/2015
Bayer AG (BAYZF) May Have a Buyer for Diabetes Biz 2/23/2015
Ferring Pharmaceuticals Acquires Novel Drug Delivery Technology From CTCBIO Inc. 2/23/2015
EXCLUSIVE: Evercore ISI Breaks Down Valeant (VRX) / Salix (SLXP) Deal By the Numbers 2/23/2015
Shire (SHPGY) Completes Acquisition Of NPS Pharmaceuticals, Inc. (NPSP) 2/23/2015
Sosei Snags UK Biotech Firm Heptares for $400 Million 2/23/2015
Management Buy Out Of Synexus Backed By LDC; The Deal Will Enable It To Further Expand Its Global Network 2/23/2015
Actavis (ACT) to Officially Adopt Allergan (AGN) Name 2/20/2015
Ferring Pharmaceuticals Acquires Two Phase III Ready Orthobiologic Product Candidates From BioSET 2/19/2015
Endo Pharmaceuticals (ENDP) Rumored to be Battling Shire (SHPGY), Valeant (VRX) for Salix (SLXP)'s Affections 2/18/2015
Crown Bioscience, Inc. Buys PDX Unit From Molecular Response (MRL) 2/18/2015
Amneal, Pfizer (PFE), Novartis AG (NVS) Eye Takeover of CLARIS Lifesciences's Injectables Biz 2/17/2015
Week in Review: Cellular Biomedicine Group (CBMG) In-Licenses Cancer Immunotherapy From China 2/16/2015
Novartis AG (NVS) Eyes Israeli Companies 2/16/2015
Look Out Valeant (VRX), Shire (SHPGY) Wants to Continue Spending Spree With Salix (SLXP) Bid 2/16/2015
Intrexon Corporation Snaps Up Belgium Startup ActoGeniX for $60 Million 2/13/2015
GlaxoSmithKline (GSK) Takes Full Control of GlycoVaxyn AG for $190 Million 2/11/2015
BIOCEO15: Financial Panel Sees Deal-Making Up in 2015, Names CAR-T, Plaque Attackers as Hot Targets 2/9/2015
Cellular Biomedicine Group (CBMG) Acquires CAR-T Technology From China Hospital 2/9/2015
AstraZeneca PLC (AZN) Slams Down $600 Million for Actavis (ACT) Lung Unit 2/5/2015
Hainan Shuangcheng Buys Hangzhou Ausia Biotech Stake For $154 Million 2/4/2015
Harbin Gloria Pharmaceuticals (002437.SZ) Acquires Shanxi Powerdone For $380 Million 2/4/2015
Mylan Inc. (MYL) to Become a Women's Healthcare Powerhouse With $800 Million Buy 2/3/2015
ICON Snaps Up MediMedia Pharma Solutions for $120 MIllion Cash 2/2/2015
Sanofi (SAN.PA)'s Increased Stake in Alnylam Pharmaceuticals (ALNY) Points Toward a Possible Acquisition 2/2/2015
Endo Pharmaceuticals (ENDP) Completes Acquisition Of Auxilium Pharmaceuticals (AUXL) 1/30/2015
AstraZeneca PLC (AZN) Rumored to be Stalking Massachusetts's Ariad Pharmaceuticals, Inc. (ARIA) 1/29/2015
Pharma Giant Merck & Co. (MRK) Scoops Up UK Software Firm for Undisclosed Amount 1/29/2015
Actavis (ACT)' Buying Spree Continues With $460 Million Deal 1/27/2015
genae Buys e-novex 1/27/2015
Biolin Scientific Acquires The Key Patent Protecting Multi-Hole, High-Throughput Ion Channel Screening 1/27/2015
Novartis AG (NVS) CEO Taking a Hard Look at Swiss Costs, Possible Bolt-On Acquisitions 1/26/2015
3SBio Inc. (SSRX) Acquires Sirton Pharmaceuticals SpA 1/26/2015
AMATSIGROUP Acquires SEPS Pharma In Belgium, To Continue Its International Expansion And Strengthen Its Formulation Expertise 1/26/2015
Aspen Pharmacare Ltd. Grabs Rights to Novartis AG (NVS)'s Mono-Embolex for $142.3 Million 1/23/2015
With Cash in the Bank, Incoming Takeda (TKPYY) CEO Eyes M&A Opportunities 1/22/2015
Piramal Snaps Up Coldstream Laboratories Inc. for $30.65 Million 1/21/2015
Boehringer Ingelheim Corporation Considering Sale of Its U.S.-Based Generics Biz 1/19/2015
Buying Spree Continues as Roche (RHHBY) Picks Up Trophos in $540 Million Deal 1/19/2015
Fresh Off Its Biggest Buy Yet, Shire (SHPGY) Already Hints at Another One 1/13/2015
Teva Pharmaceutical Industries Limited (TEVA) May Need to Jump Onto the Takeover Bandwagon Soon 1/12/2015
Amarantus BioSciences, Inc. Announces Acquisition Of Specialized Neuro-Diagnostics Company, DioGenix 1/12/2015
Actavis (ACT) And Allergan (AGN) Announce Early Termination Of Hart-Scott-Rodino Waiting Period For Actavis' Pending Acquisition Of Allergan And Record Dates For Shareholder Meetings 1/12/2015
Shire (SHPGY) Officially Snaps Up NPS Pharmaceuticals, Inc. (NPSP) in $5.2 Billion Deal 1/12/2015
WuXi PharmaTech Co., Ltd. Acquires NextCode Health For $65 Million 1/9/2015
WuXi PharmaTech Co., Ltd. Acquires NextCode Health To Create Global Leader In Genomic Medicine 1/9/2015
BTG plc (BTG.L): Completion Of The Acquisition Of PneumRx Inc. 1/8/2015
Horizon Discovery Group plc Acquires Haplogen Genomics GmbH 1/8/2015
Advanced Accelerator Applications Fully Acquires Atreus Pharmaceuticals, Inc.; Enrolls First Patient In A Phase 1/2 Clinical Trial For Its Key Diagnostic Candidate Annexin V-128 In Rheumatoid Arthritis And Ankylosing Spondylitis 1/8/2015
Crown Bioscience, Inc. Expands Operations And Re-Brands UK Site 1/8/2015
Gilead Sciences, Inc. (GILD) Snaps Up Liver Disease Treatment from Phenex Pharmaceuticals AG in $470 Million Deal 1/6/2015
Cardio3 BioSciences Moves Into Oncology With $182 Million Deal 1/6/2015
Pfizer (PFE) Takes Controlling Interest In Startup; Grabs Access of Preclinical CMV Candidate 1/5/2015
SRF Snaps Up DuPont (DD)'s Pharma Propellant Biz for $20 Million 1/2/2015
AstraZeneca PLC (AZN) CEO Believes New Pfizer (PFE) Bid Unlikely 12/29/2014
Spending Spree Continues as Actavis (ACT) Considers Near $3 Billion Bid for Almirall 12/24/2014
Roivant Acquires SB742457 From GlaxoSmithKline (GSK) 12/23/2014
Roche (RHHBY) To Pay Up To $489 Million For Next-Gen Antibody Firm Dutalys 12/22/2014
Shire (SHPGY) May Spend AbbVie (ABBV) Breakup Fee On NPS Pharmaceuticals, Inc. (NPSP); NPS Surges On Rumor 12/19/2014
KCR Acquires Project Portfolio From Ukrainian CRO AXIS 12/18/2014
RedHill Biopharma Ltd. (RDHL) Acquires Technology From University of Minnesota As Part Of Ongoing RHB-104 Phase 3 Crohn's Program 12/18/2014
UCB SA Terminates $1.53 Billion Sale Of Generic Drug Unit To Buyout Firms 12/17/2014
Evolva A/S Unloads EV-035 Series To Emergent BioSolutions (EBS) For $70.5 Million Plus 12/17/2014
Novartis AG (NVS) Takes Stake In Israeli Biopharma BioLine; Makes $10 Million Investment 12/16/2014
Renmatix Acquires Sweden-Based REAC Fuel's Intellectual Property 12/16/2014
Sosei Group Corporation Acquires Jitsubo, A Leading Japanese Peptide Technology Company 12/12/2014
Cipla Ltd. Sells Stake In Jiangsu Cdymax Pharma For $18.5 Million 12/12/2014
Interim CEO Says Sanofi (SAN.PA) Continuing Diversification, Eyeing Acquisitions 12/10/2014
China, South Korea OK GlaxoSmithKline (GSK)'s $43B Covidien (COV) Buy 12/5/2014
Speculation Mounts That Pfizer (PFE) Will Up Bid For AstraZeneca PLC (AZN) As Cooling Off Period Ends 12/5/2014
Forbion Announces Sale Of Portfolio Company PneumRx Inc. To BTG plc (BTG.L) For Up To EUR 385M (USD 475M) 12/4/2014
Roche (RHHBY) Acquires Ariosa Diagnostics, Inc. And Enters The Non-Invasive Prenatal Test (NIPT) And Cell-Free DNA Testing Services Markets 12/3/2014
Alizé Acquires Exclusive Worldwide Rights On A New Peptide To Tackle Bone Diseases 12/3/2014
Shanghai Fosun Buys 65% Stake In Suzhou Erye Pharma 12/3/2014
Otsuka Pharmaceutical Co., Ltd. Buys AVANIR Pharmaceuticals (AVNR) For $3.5 Billion 12/2/2014
Pfizer (PFE) Announces Completion Of Merger With Wyeth 12/2/2014
European Commission (EC) Regulators Mull Novartis AG (NVS), GlaxoSmithKline (GSK) Deals As January Deadline Looms 12/1/2014
Contera Pharma Announces Acquisition By Korean Bukwang Pharmaceutical 12/1/2014
Imaflex Acquires Controlled-Release Agricultural Mulch Film Assets From Bayer AG (BAYZF) 12/1/2014
Regen BioPharma Acquires University of Toronto Cancer Stem Cell Intellectual Property 11/25/2014
AbbVie (ABBV) Acquires Manufacturing Facility In Singapore; Further Expands Capabilities In Asia 11/21/2014
Endo Pharmaceuticals (ENDP) Announces Early Termination Of HSR Act Waiting Period In Connection With Its Proposed Acquisition Of Auxilium Pharmaceuticals (AUXL) 11/19/2014
Recipharm AB Bags Lusomedicamenta For $140 Million 11/14/2014
Jubilant Life Sciences (JOL) Seeks To Complete Buyout Of U.S.-Based Cadista For Up To $33.2 Million 11/14/2014
PE Firm To Bid For GlaxoSmithKline (GSK)'s $3 Billion Mature Drugs Portfolio 11/14/2014
Sanofi (SAN.PA) Unloads Large Office In India 11/13/2014
Nuvo Research Inc. (NRI.TO) Reacquires Pennsaid® 2% Rights To South America, Central America, South Africa And Israel 11/13/2014
Thailand-Based SCG Acquires Stake In Liechtenstein-Based Research Company Lysando AG 11/12/2014
AstraZeneca PLC (AZN) Is Building Value Without Pfizer (PFE): CEO 11/11/2014
Johnson & Johnson (JNJ) Chief Eyes Acquisitions In China 11/10/2014
UCB Group (UCBJF.PK) Divests U.S. Generics Unit For $1.53 Billion 11/7/2014
GVK BIO Signs Definitive Agreement To Acquire Vanta Bioscience 11/6/2014
Perrigo (PRGO) Snatches Up Omega Pharma NV (0OMEP.BR) For $4.5 Billion 11/6/2014
AstraZeneca PLC (AZN) Builds Cancer Immunotherapy Capabilities With $150 Million Definiens AG Buy 11/4/2014
Univar Expands in Brazil Market With Acquisition Of D'Altomare Quimica Ltda. 11/4/2014
Taiyo Pacific Partners Becomes Major Shareholder In Peptidream With Stake Over 5% 11/4/2014
AbbVie (ABBV) Not Looking For Massive Deals After Abandoning Shire 11/3/2014
Actavis (ACT) And Durata Therapeutics, Inc.  (DRTX) Receive U.S. FTC Clearance For Actavis' Proposed Acquisition Of Durata 11/3/2014
Deal-Starved Perrigo (PRGO) In Exclusive Talks To Buy $5 Billion+ Omega Pharma NV (0OMEP.BR) 10/31/2014
Bayer AG (BAYZF) Hunts For More Deals After Bulking Up Consumer Care 10/30/2014
Novartis AG (NVS) Sells Flu Vaccine Business For $275 Million To CSL Limited (CMXHF.PK) 10/28/2014
Luye Pharma Pays $390 Million For Remaining 42% Of Beijing Jialin Pharma 10/28/2014
Zogenix, Inc. (ZGNX) Snags U.K.-Based Brabant Pharma In $35 Million Cash-Stock Deal 10/27/2014
Private Equity Eyes $13 Billion Bayer AG (BAYZF)'s Plastics Business 10/24/2014
Mylan Inc. (MYL), Abbott Laboratories (ABT) Tweak $5 Billion Tax Inversion Deal 10/23/2014
Therapix Signs Non-Binding Agreement to Acquire Dekel Pharmaceuticals Ltd. 10/21/2014
Actavis (ACT) Will Compete With Sanofi (SAN.PA) For $5.1 Billion Omega Pharma NV (0OMEP.BR) Deal 10/21/2014
Lupin Ltd. (LUPN.BO) Scouts For Acquisitions In U.S. 10/21/2014
Shire Goes Shopping After AbbVie (ABBV) Deal Falls Through 10/21/2014
AbbVie (ABBV) Officially Abandons Shire 10/21/2014
Fresenius AG, Buyout Groups Eye Danone Medical Nutrition Unit 10/20/2014
AbbVie (ABBV) Board Officially Abandons $55 Billion Shire Merger 10/17/2014
Virax To Acquire Deep AKT Inhibitor Portfolio Already In Phase 1b/2 Breast & Phase 1b Ovarian Cancer Trials 10/17/2014
Horizon Biopharm Pays $45 Million Cash For U.S. Rights To PENNSAID® 2% 10/17/2014
DiaGenic ASA: Completed Acquisition Of NEL Hydrogen – Company Name And Ticker To Be Changed 10/17/2014
Shire Plummets As AbbVie (ABBV) Reconsiders $55 Billion Takeover Bid 10/16/2014
Analysts Still See AstraZeneca PLC (AZN) As Viable Takeover Target 10/15/2014
Geographic Split Likely For GlaxoSmithKline (GSK) Mature Drugs Sale 10/15/2014
MorphoSys AG Acquires Lanthipeptide Technology From Lanthio Pharma 10/15/2014
Oxford BioMedica PLC (OXB.L) Acquires Windrush Court Office And Laboratory Facilities 10/13/2014
GlaxoSmithKline (GSK) Takes A 25% Stake In Aspen Pharmacare Ltd. Japanese Unit 10/9/2014
Endo International plc (ENDP) Pays $2.6 Billion For Auxilium Pharmaceuticals (AUXL), Auxilium Drops QLT Inc. (QLTI) Deal 10/9/2014
DiaGenic ASA Signed Final Agreement To Acquire NEL Hydrogen AS – Extended Announcement 10/8/2014
Teva Pharmaceutical Industries Limited (TEVA) To Stop R&D In Cancer And Women's Health; 14 Pipeline Projects To End, Divest 10/7/2014
Top Managers Argue Over What To Do With Sanofi (SAN.PA)'s $8 Billion Drug Portfolio 10/7/2014
Analyst Dismisses Teva Pharmaceutical Industries Limited (TEVA)-Mylan Inc. (MYL) Merger Rumor 10/7/2014
Week in Review: WuXi PharmaTech Co., Ltd. Acquires XenoBiotic Laboratories, Inc. , A US-China CRO 10/6/2014
Actavis (ACT) Finally Makes A Move, Pays $675 Million For Durata Therapeutics, Inc.  (DRTX) 10/6/2014
Salix Pharmaceuticals, Ltd. (SLXP) Linked With Actavis (ACT) After Calling Off Cosmo Pharmaceuticals S.p.A. Merger Amid Inversion Crackdown 10/3/2014
Immutep S.A. Picks Up Prima Biomed (PRR.AX) For $28 Million 10/2/2014
Prima Biomed (PRR.AX) Secures $37.4 Million To Fund Immutep S.A. Acquisition 10/2/2014
Consort Medical Scoops Up Aesica For $374 Million 10/1/2014
WuXi PharmaTech Co., Ltd. Laboratory Testing Division Expands In U.S. With Acquisition Of XenoBiotic Laboratories, Inc. 10/1/2014
Recipharm AB Completes Acquisition Of Corvette Pharmaceutical Services Group For SEK1.1 Billion 10/1/2014
Strides Arcolab Limited Snags Shasun Pharma In All Stock Deal Worth Over $221 Million 9/30/2014
Chiltern International Ltd. Acquires Pacific Clinical Research Pte Limited And Expands Operations And Therapeutic Depth In Asia-Pacific 9/29/2014
Daiichi Sankyo, Inc. (4568.t) Boosts Cancer Pipeline With $410 Million Ambit Biosciences Buy 9/29/2014
Hikma Pharmaceuticals Eyeing $1 Billion Bid For U.S. Rival CorePharma LLC 9/29/2014
Pfizer (PFE) Approached Actavis (ACT) For Possible Merger 9/24/2014
Merck KGaA (MKGAF.PK) To Pay $17 Billion For St. Louis-Based Sigma-Aldrich Corporation (SIAL) 9/23/2014
Bionomics Limited (BNO.AX) Acquires Prestwick Chemical 9/23/2014
Hikma Pharmaceuticals Completes Acquisition Of Ben Venue Laboratories Manufacturing Site 9/17/2014
Auxilium Pharmaceuticals (AUXL) Institutes "Poison Pill" To Fend Off $2.2B Endo Pharmaceuticals (ENDP) Offer 9/17/2014
Illinois-Based Akorn, Inc. (AKN) Eyes $2 Billion UCB SA Unit In Potential Tax Inversion Deal 9/12/2014
ReproCELL Acquires The iPS Cell Business Unit Of Stemgent, Inc. 9/9/2014
Cellectis (ALCLS) Announces The Closing Of The Sale Of Its Swedish Subsidiary Cellectis AB To Takara Bio 9/4/2014
China Biologic Products Completes Transaction To Acquire Additional Equity Stake In Guizhou Taibang 9/4/2014
Mercachem Holding B.V. To Acquire Prague Business From Synthon 9/3/2014
AstraZeneca PLC (AZN) Pops On Possibility Of Another Pfizer (PFE) Bid; Start Of New Cancer Trial 9/2/2014
Luye Pharma Buys Majority Stake In Beijing Jialin For $599 Million 8/29/2014
Bayer AG (BAYZF), Boehringer Ingelheim Corporation, Perrigo Company (PRGO), And Sanofi (France) (SAN.PA) Linked To Omega Pharma NV (0OMEP.BR) Sale; Deal Could Cost More Than $5.3 Billion 8/29/2014
Novo Nordisk A/S (NVO) Prefers To Grow On Its Own, Not Buy Others: CEO 8/27/2014



//-->